Restructuring
Novirio becomes Idenix Pharmaceuticals, Inc.
Published in Hepatitis Weekly, July 8th, 2002
The new name, Idenix, is intended to reflect the application of its drug discovery expertise and development experience in the areas of hepatitis B, hepatitis C and HIV and the potential application of this expertise and experience to the treatment of other infectious diseases.
Idenix is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases.
Idenix's current focus is on the treatment of infections caused by hepatitis B virus, hepatitis C virus, and human...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2002-07-08)
More Articles from Hepatitis Weekly
- Disease Associations
Brazilian study finds link between hepatitis C and non-Hodgkin lymphoma - Geriatrics
Ischemic hepatitis is uncommon but still detectable among the elderly - Hepatitis C
NIDDKD summarizes progress and future directions for management - Transplantation
Hepatitis B virus genotype rules outcomes following liver transplantation - COX-2
Selective enzyme inhibitor NS-398 arrests the growth of liver cancer cells - Hepatitis C Therapy
Schering-Plough reports on Peg-Intron and Rebetol combination therapy for hepatitis C - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
